The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

In support of three coordinated CCSG components reducing our national burden of cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

As we are all aware, the new presidential administration is moving rapidly to change how science, including health sciences, will be conducted and funded by the federal government, including research supported by the National Institutes of Health. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Shine Chang, PhD
Ashbel Smith Professor & University of Texas System Distinguished Teaching Professor, Department of Health Disparities Research, Director, Cancer Prevention Research Training Program, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center
Michaela A. Dinan, PhD
Associate professor, Department of Epidemiology Chronic Disease, Yale School of Public Health, Associate cancer center director, Cancer Research Education and Training, Co-leader, Cancer Prevention and Control Program, Yale Cancer Center, Co-director, Cancer Outcomes, Public Policy & Effectiveness Research (COPPER) Center, Yale School of Medicine
Miria Kano, PhD
Morton Cohen Cancer Center Endowed Chair, Associate professor of community & behavioral health, Colorado School of Public Health, CU Anschutz Medical Campus, Associate Director, Engagement, Access & Success, CU Cancer Center 
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

I was really excited to get to talk about the role that mentorship plays in women’s leadership development. It’s a topic that I’ve thought a lot about, and also that I’ve benefitted from, and that I think is not always applied with enough intention. There is an art to mentorship, and I want to share some of how that has helped me navigate career transitions and pivot to leadership roles.
By W. Kimryn Rathmell
Byline
Shine Chang, PhD
Ashbel Smith Professor & University of Texas System Distinguished Teaching Professor, Department of Health Disparities Research, Director, Cancer Prevention Research Training Program, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center
Michaela A. Dinan, PhD
Associate professor, Department of Epidemiology Chronic Disease, Yale School of Public Health, Associate cancer center director, Cancer Research Education and Training, Co-leader, Cancer Prevention and Control Program, Yale Cancer Center, Co-director, Cancer Outcomes, Public Policy & Effectiveness Research (COPPER) Center, Yale School of Medicine
Miria Kano, PhD
Morton Cohen Cancer Center Endowed Chair, Associate professor of community & behavioral health, Colorado School of Public Health, CU Anschutz Medical Campus, Associate Director, Engagement, Access & Success, CU Cancer Center 
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account